´╗┐

CCS-Bayer Resident Vascular Award

This Award is intended for Canadian clinical trainees (PGY 4-6) for a research project on any topic related to thrombosis, anticoagulation, stroke, or atrial fibrillation.

The program is particularly interested in research that has the potential to advance knowledge about or improve the care of patients at risk for vascular, thrombotic or embolic events.

Three awards totalling up to $45,000 will be awarded based on an independent peer review process. A bonus award of $5,000 will be awarded by the CCC session audience to one of the three finalists for the most effective and persuasive presentation. Funded research must be completed within 48 months from the start of funding. 

The deadline for submission to the 2020 CCS-Bayer Resident Vascular Award is September 14, 2020.

Awardees will be notified by October 1, 2020.

Apply now

CCS-Bayer Resident Vascular Award Application Handbook

 

 

  • Eligibility

    • Applicants must be enrolled in a Canadian clinical training program (PGY 4-6) for, but not limited to, adult or pediatric cardiology, cardiac or vascular surgery.

    • Must be a CCS Member. For more information about CCS Membership, visit the CCS website

    • Funds are intended for Canadian Research purposes

    • Applicants must be available to present their research projects to the judging panel during a virtual session at the Canadian Cardiovascular Congress (CCC), in October 2020. Finalists will be provided complimentary registration to CCC 2020.

  • The Award

    Three awards will be awarded based on an independent peer review process
    Award Prizes:

    • 1st prize: $20,000

    • 2nd prize: $15,000

    • 3rd prize: $10,000

    An additional $5,000 prize to be awarded by the CCC session audience to one (1) of the three (3) finalists for the most effective and persuasive presentation.

    Funds will be administered by the Cardiology Division of the awardee’s affiliated university or equivalent.

  • Terms of Reference and submission guidelines

    • Applicants are asked to submit a proposal, including the following:

    • Outline of the project. Is the project part of a larger study or grant? If so, please explain.

    • Description of the research environment. Where will the research project be conducted (research must be conducted in Canada).

    • If the scope of the project is greater than the funds awarded, the applicant must explain what area the grant will be used in. If other member(s) of the team is/are involved in the project, applicant is to describe his/her role in the study.

    • Budget - Is the project partially funded using other channels? If so, please explain. As an attachment, template provided below.

    • A brief 1-page curriculum vitae outlining any prior research experience and publications. As an attachment.

    • Hi-resolution photo

    • Name of mentor or supervisor

    • Name and contact information of the Payee – both the Institution and individual who will receive the funds.

  • The Process

    An evaluation committee chaired by Dr. Jeff Healey and consisting of Drs. Katia Dyrda, Jean-François Tanguay, Rob Welsh and, Lena Rivard will review all applications and select the three (3) most meritorious finalists.

    Evaluation of applications will be based on three (3) criteria: quality, and feasibility of project, quality of applicant, research environment and mentor.

    These three (3) finalists will present their research project at a virtual session held during the Canadian Cardiovascular Congress (CCC) in October 2020. During a 10-minute presentation, they will have the opportunity to present the research project and answer questions from the judging panel above.

    Following the three (3) presentations, each of the three (3) finalists will be awarded a Vascular Award.

  • Background Information

    Additional Important Proposal Submission Information

    1. Current PGY 4-6 clinical trainees in, but not limited to, adult or pediatric cardiology, cardiac or vascular surgery in a Royal College of Physicians and Surgeons approved program are eligible to submit a proposal.

    2. Applicants must currently reside in Canada.

    3.  Award funds are solely intended for Canadian research purposes.

    4. The award funds will be administered by the institution of the finalists’ affiliated universities.

    5. The award and funds are intended for original research conducted by residents and should not supplement funding for an ongoing project.

           a) If the submission refers to a multicenter clinical trial, the applicant must specify their specific role in the research study.

           b) If the application is for a sub-study of an ongoing project or trial, the applicant must specify their role and explain how the sub-study is distinct from the main study.

    6. If the scope of the project is greater than the funds awarded, the applicant must explain what area the grant will be used in. If another member of the team is involved in the project, the applicant is to describe his/her role in the study.

    7. Award funds will range from $20,000 (if 1st prize), $15,000 (2nd prize), $10,000 (3rd prize) and a bonus prize of $5,000 for the best presentation. The scope of the project must be flexible to accommodate this range of budget. The funds awarded may be used as a standalone or may be further leveraged by applying for funding from another source.

    8. Mentor name, affiliation, and qualifications must be provided at the time of proposal submission.

    9. Application should not include superfluous content (cover page, table of content, etc.).

    10. The final stage of the competition process is performance-based: be prepared to defend your proposal during a CCC session in October 2020, as you may encounter challenging questions from the reviewers. Contestants must be prepared to answer tough questions with brief and succinct statements.

    11. The Canadian Cardiovascular Society will announce the finalists in late September 2020. The ranking (first, second, and third place) will be voted by judges during the CCC session in October 2020, following presentations by finalists. The winner of the $5,000 presentation bonus will be decided by the audience during the session.

    12. As the audience will have a vote during the session to allocate the $5,000 presentation bonus to one of the three finalists, we encourage finalists to invite their colleagues to attend the session to cheer them on.

    13. The finalists must submit a photo and brief resume to be published on the award website at http://www.ccs.ca/en/award-winners

    14. Applicants must be available for the CCC 2020 to present their research projects to the judging panel during a virtual session in October 2020. Finalists will be provided a complimentary registration to attend the CCC.

    15. Research status report will be requested and should be submitted on October 1st of the ensuing year(s) that the project is running.

    16. Upon completion of the project, there is an expectation that the output of the research be submitted for presentation at cardiovascular congresses like the CCC. The submission must acknowledge the source of the research funding, the CCS-Bayer Resident Vascular Award.

  • The Peer Review Process and Evaluation Committee

    All applications will be pre-screened for eligibility. Applications that are late, incomplete and/or do not meet the basic eligibility criteria will be not be considered for review. Peer review of all eligible applications will be conducted by a scientific review committee comprised of CCS members. Reviewers are selected for their expertise in cardiac arrhythmias. All eligible proposals will be reviewed by at least two members of the peer review committee. All applicants will receive feedback from reviewers, upon request.

  • Past recipients of the CCS-Bayer Vascular Award

    2019

    1st prize ($20,000) Pietro Di Santo
    Research Project: Direct Oral Anticoagulation Post-Transradial Access for the Prevention of Radial Artery Occlusion
    Mentor: Dr. Benjamin Hibbert

     

    2nd prize ($15,000) Pishoy Gouda
    Research Project: An Externally Validated Prediction Tool for Peripheral Arterial Disease in Patient with Documented Coronary Artery Disease
    Mentor: Dr. Robert Welsh

    3rd Prize ($10,000) + Presentation Bonus ($5,000) Alice Chang
    Research Project: Beyond Atrial Fibrillation: Using Artificial Intelligence, Big Data and Imaging to Improve Stroke Risk Assessment and Management
    Mentor: Dr. Teresa Tsang


    2018

    1st prize ($20,000) Ali Alsagheir MSc, MD
    Research Project: Low INR to Minimize bleeding with mechanical valves Trial (LIMIT) Pilot
    Mentor: Dr. Richard P. Whitlock

    2nd prize ($15,000) + Presentation Bonus ($5,000)  Jari M. Tuomi PhD, MD
    Research Project: Ibrutnib, dose dependently, promotes atrial fibrillation in mice by depressing cardiac conduction
    Mentors: Dr. Robert Rose PhD and Dr. Doug Jones PhD

    3rd Prize ($10,000) + Presentation Bonus ($5,000) Graham McClure MSc, MD
    Research Project:VANGuARD @ ICES (Vascular comANaGement in peripherAl aRterial Disease) Provincial registry analysis of outcomesin peripheral arterial disease with and without vascular medicine specialist referral
    Mentor: Dr. Richard P. Whitlock

    2017

    1st prize ($20,000) and Presentation Bonus ($10,000) Thomas M. Roston, MD
    Research Project: Cardiac RyAnodine receptor Variants in Early-onset Atrial Fibrillation: The CRAVE-AF Study
    Mentors: Dr. Andrew Krahn and Dr. Zachary Laksman

    2nd prize ($12,500) Michael Chiu, BSc, MD, MSc, FRCPC
    Research Project: Heat Shock Protein 27: A Potential Biomarker for Atrial Fibrillation
    Mentor: Dr. Edward O'Brien

    3rd prize ($7,500) Amine Mazine, MD, MSc
    Research Project: A Pilot Echocardiographic and CT Imaging Study to Evaluate Subclinical Leaflet Thrombosis Following Surgical Bioprosthetic Aortic Valve Replacement
    Mentor: Dr. Subodh Verma

    2016

    1st prize ($20,000) and Presentation Bonus ($10,000) Christopher Cheung, MD
    Research Project: Does Intensive Monitoring Improve Diagnosis and Treatment of Atrial Fibrillation after Myocardial Infarction?

    2nd prize ($12,500) Derrick Tam, BSc, MD, PGY3 Cardiac Surgery
    Research Project: Improving Outcomes in Cardiac Surgery through Reduction in Readmission: A Novel Risk Stratification Tool

    3rd prize ($7,500) Tina Zhu, MD, FRCPC, PGY5 Cardiology
    Research Project: Carotid Contrast-Enhanced Ultrasound (CEUS) as a Risk Stratification Tool for Cardiovascular Disease

    2015

    1st prize ($20,000) and Presentation Bonus ($10,000) William F. McIntyre, MD, FRCPC
    Research Project: Atrial Fibrillation Occurring Transiently with Stress (AFOTS) Understanding the Risks of Subsequent AF and Stroke

    2nd prize ($12,500) Saman Rezazadeh, PhD, MD, FRCPC
    Research Project: Automated Reminder to Initiate Oral Anticoagulation in Patients with Atrial Fibrillation/Atrial Flutter Discharged Directly From the Emergency Department: REMINDER STUDY

    3rd prize ($7,500) Hadi Toeg, MD, MSc, MPH, PGY5 Cardiac Surgery
    Research Project: Hybrid Coronary Revascularization in Diabetics (HYCARDS) Randomized

    2014

    1st prize ($20,000) and Presentation Bonus ($10,000) Guillaume Marquis Gravel, MD, MSc
    Research Project: The Bromocriptine in Heart Failure (BRO-HF) Initiative

    2nd prize ($12,500) Iqbal H. Jaffer, BA (Hons), MBBS
    Research Project: Prevention of Clotting on Mechanical Heart Valves

    3rd prize ($7,500) Abhinav Sharma, MD, FRCPC (Internal Medicine), ABIM
    Research Project: In patients with heart failure, does diabetic status influence clinical outcomes?

 

 

If you have any questions or require support preparing or submitting your application, please email This email address is being protected from spambots. You need JavaScript enabled to view it..

Supported by:

The Canadian Cardiovascular Society and Bayer Inc. are proud to support the CCS-Bayer Resident Vascular Award. With this award, we hope to further research in thrombosis, anticoagulation, stroke, or atrial fibrillation to improve the lives of Canadians who are affected by these conditions, and their families.

 

ccs              

 

Bayer Logo Cross